FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Must Correct on Rare Diseases, Not Overcorrect: Column

A RealClear Health column urges FDA not to overcorrect as it reconsiders its approach to investigational rare disease therapies.

latest-news-card-1
Human Drugs

Rescind Filing of 2 Zydus Applications: Gilead

Gilead petitions FDA to rescind its acceptance for filing of two Zydus 505(b)(2) applications for drugs that Gilead says are duplicates of its Descovy...

latest-news-card-1
Medical Devices

Neptune Medical Robotic Endoscopy Cleared

FDA clears a Neptune Medical 510(k) for its Triton 1 System, a robotic system for next-generation flexible endoscopy.

latest-news-card-1
Human Drugs

Sen. Warren Continues to Push for TrumpRx Contracts

Sen. Elizabeth Warren says she is continuing to push Trump officials to release the actual contracts that have been signed with drug companies that ar...

latest-news-card-1

Prepare for Enhanced FDA/SEC Oversight: Sidley

Sidley attorneys say regulated companies should expect heightened federal government oversight due to a recent information-sharing memorandum of under...

latest-news-card-1
FDA General

Senate Looks to Rush Overtons FDA Head Nomination: Report

The Senate HELP Committee prepares to hold a confirmation hearing for FDA commissioner nominee Heidi Overton as soon as next week.

latest-news-card-1
Human Drugs

FDA Adds Kybella Warning Over Serious Risks From Off-Label Injections

FDA approves new safety warnings for AbbVies Kybella (deoxycholic acid) after identifying serious adverse events when the fat-dissolving drug was inje...

latest-news-card-1
Human Drugs

FDA Finalizes Guide on Use of Buffy Coat Blood Processing

FDA finalizes a guidance intended to facilitate development of blood collection, processing and storage systems that would allow U.S. blood establishm...

latest-news-card-1
Human Drugs

Bill to Make Pediatric Rare Disease Voucher Permanent

Six House members introduce bipartisan legislation to make the FDA Rare Pediatric Disease Priority Review Voucher Program permanent.

latest-news-card-1
FDA General

Cassidy Remains Noncommittal on Overton FDA Nomination After Meeting

Senate HELP Committee chairman Bill Cassidy (R-La.) keeps mum on any potential support for FDA commissioner nominee Heidi Overton following a meeting ...